Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review

Depression is the most prevalent psychiatric disorder in the world, affecting 4.4% of the global population. Despite an array of treatment modalities, depressive disorders remain difficult to manage due to many factors. Beginning with the introduction of fluoxetine to the United States in 1988, sele...

Descripció completa

Dades bibliogràfiques

Autors principals:	Amber N. Edinoff, Haseeb A. Akuly, Tony A. Hanna, Carolina O. Ochoa, Shelby J. Patti, Yahya A. Ghaffar, Alan D. Kaye, Omar Viswanath, Ivan Urits, Andrea G. Boyer, Elyse M. Cornett, Adam M. Kaye
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2021-08-01
Col·lecció:	Neurology International
Matèries:	selective serotonin reuptake inhibitors adverse effects suicidality
Accés en línia:	https://www.mdpi.com/2035-8377/13/3/38
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!